The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujinaga, K.
Right arrow Articles by Ikuta, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujinaga, K.
Right arrow Articles by Ikuta, K.

The Journal of Immunology, Vol 155, Issue 11 5289-5298, Copyright © 1995 by American Association of Immunologists


ARTICLES

Extracellular Nef protein regulates productive HIV-1 infection from latency

K Fujinaga, Q Zhong, T Nakaya, M Kameoka, T Meguro, K Yamada and K Ikuta
Section of Serology, Hokkaido University, Kita-ku, Sapporo, Japan.

In HIV-1-infected asymptomatic carriers, the vast majority of infected cells in PBMCs are believed to be latently or nonproductively infected. We have isolated a subclone (MOLT-20-2) from an infected T cell line that expressed HIV-1 Ags at a very low level. However, viral Ag expression was markedly up-regulated by stimulation with either TNF- alpha, A23187, or PMA, indicating that the subclone might provide a suitable model of HIV-1 latency. Our previous studies have shown that the carboxyl-terminal region of the extracellular form of HIV-1 Nef played an important role in the interaction of infected cells with uninfected T cells, and could induce the cytostatic state. This suggested that Nef might contribute to intracellular signal transduction through an interaction with latently infected cells. We show in this study that stimulation of MOLT-20-2 with soluble Nef leads to HIV-1 activation from latency in a dose-dependent manner. Moreover, using a total of 14 overlapping Nef-related synthetic peptides, stimulatory activity was mapped to a discrete peptide (amino acid residues 132-147) that had the potential to activate latent HIV-1. This novel Nef function was confirmed by activation of virus production from the PBMCs of asymptomatic carriers. In addition, Nef-dependent HIV-1 activation from latency was also observed in another independently derived, latently infected cell line, U1, though not in cell line ACH- 2. These results extend the significance of the Nef activity in vivo to the regulation of productive HIV-1 infection from latency, and define the regions of the protein involved.


This article has been cited by other articles:


Home page
J. Virol.Home page
O. Kutsch, E. N. Benveniste, G. M. Shaw, and D. N. Levy
Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency
J. Virol., July 29, 2002; 76(17): 8776 - 8786.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Speth, T. Schabetsberger, I. Mohsenipour, G. Stockl, R. Wurzner, H. Stoiber, C. Lass-Florl, and M. P. Dierich
Mechanism of Human Immunodeficiency Virus-Induced Complement Expression in Astrocytes and Neurons
J. Virol., March 7, 2002; 76(7): 3179 - 3188.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig
Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis
Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 725 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Gahéry-Ségard, G. Pialoux, B. Charmeteau, S. Sermet, H. Poncelet, M. Raux, A. Tartar, J.-P. Lévy, H. Gras-Masse, and J.-G. Guillet
Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine
J. Virol., February 15, 2000; 74(4): 1694 - 1703.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
U. Koedel, B. Kohleisen, B. Sporer, F. Lahrtz, V. Ovod, A. Fontana, V. Erfle, and H.-W. Pfister
HIV Type 1 Nef Protein Is a Viral Factor for Leukocyte Recruitment into the Central Nervous System
J. Immunol., August 1, 1999; 163(3): 1237 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Salvi, A. R. Garbuglia, A. Di Caro, S. Pulciani, F. Montella, and A. Benedetto
Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor
J. Virol., May 1, 1998; 72(5): 3646 - 3657.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K Fujinaga, T Nakaya, and K Ikuta
Generation of endogenous tumour necrosis factor-alpha in MOLT-4 cells during the acute replication phase of human immunodeficiency virus type 1 determines the subsequent latent infection
J. Gen. Virol., February 1, 1998; 79(2): 221 - 229.
[Abstract]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Brigino, S. Haraguchi, A. Koutsonikolis, G. J. Cianciolo, U. Owens, R. A. Good, and N. K. Day
Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
PNAS, April 1, 1997; 94(7): 3178 - 3182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.